SCHEMBL19625334

SCHEMBL19625334

CCOc1ccc(-c2csc(C(C)(C)C)n2)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 1/20 0.47
HTT P42858 1/20 0.45
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
CRHR1 P34998 1/20 0.41
MAPK14 Q16539 4/20 0.40
LIMK1 P53667 2/20 0.40
CDC25A P30304 1/20 0.38
CDC25B P30305 1/20 0.38
CDC25C P30307 1/20 0.38
DUSP3 P51452 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ERN1 O75460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626563 0.85 HTT (0.59) EIF4EHTTMAPTKMT2AMEN1
SCHEMBL19625333 0.82 KMT2A (0.43) HTTMAPTKMT2AMEN1CDC25A
SCHEMBL19625508 0.80 MEN1 (0.44) HTTMAPTKMT2AMEN1CDC25A
SCHEMBL19625455 0.79 MEN1 (0.43) HTTMAPTKMT2AMEN1CDC25A
SCHEMBL19625424 0.79 CDC25A (0.57) EIF4EMAPTKMT2AMEN1CDC25A
SCHEMBL19625354 0.78 MAPT (0.35) EIF4EHTTMAPTKMT2AMEN1
SCHEMBL19625323 0.76 RAB9A (0.50) HTTMAPTKMT2AMEN1CDC25A
SCHEMBL19625337 0.74 KMT2A (0.42) EIF4EMAPTKMT2AMAPK14CDC25A
SCHEMBL19625343 0.74 CDC25A (0.41) EIF4EMAPTCDC25ACDC25BCDC25C
SCHEMBL19625380 0.74 MAPK1 (0.37) EIF4EMAPTKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 EIF4E 1291/4885HTT 3968/4885MAPT 4783/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 EIF4E 1291/4885HTT 3968/4885MAPT 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.